van Veen, Sarah
Martin, Shaun
Van den Haute, Chris
Benoy, Veronick
Lyons, Joseph
Vanhoutte, Roeland
Kahler, Jan Pascal
Decuypere, Jean-Paul
Gelders, Géraldine
Lambie, Eric
Zielich, Jeffrey
Swinnen, Johannes V.
Annaert, Wim
Agostinis, Patrizia
Ghesquière, Bart
Verhelst, Steven
Baekelandt, Veerle
Eggermont, Jan
Vangheluwe, Peter
Article History
Received: 21 December 2018
Accepted: 2 December 2019
First Online: 29 January 2020
Competing interests
: Patent WO-2018002350-A1 of KU Leuven describes methods for detecting compounds with therapeutic use that target ATP13A2 or related isoforms using biological material and assays described in the current manuscript. A second patent of KU Leuven describing ATP13A2 cell models described in this manuscript has also been filed.